Difficulty: Medium
Average Score: 75%
Practice
Which analysis of maternal serum is the best predictor of chromosomal abnormalities in the fetus?
Correct answer
B
Rationale
In the context of maternal monitoring for chromosomal abnormalities in the fetus, the best predictor among the options provided is B) Multiple-marker screening. This screening test involves analyzing maternal serum for various markers such as alpha-fetoprotein, human chorionic gonadotropin, unconjugated estriol, and inhibin-A. These markers can indicate an increased risk of chromosomal abnormalities such as Down syndrome.
Multiple-marker screening is preferred over the other options for several reasons. Biophysical profile (option A) is a test used to assess fetal well-being and not specifically designed to predict chromosomal abnormalities in the fetus. The lecithin-to-sphingomyelin ratio (option C) is primarily used to assess fetal lung maturity and not for chromosomal abnormalities. Blood type and crossmatch of maternal and fetal serum (option D) are important for assessing blood compatibility but do not directly predict chromosomal abnormalities.
Educationally, understanding the rationale behind choosing multiple-marker screening can help students grasp the importance of specific tests in prenatal care. It highlights the significance of using a combination of markers to assess the risk of chromosomal abnormalities, emphasizing the need for a comprehensive approach in maternal monitoring. This knowledge is crucial for healthcare professionals involved in prenatal care to make informed decisions and provide appropriate support and counseling to expectant parents.
Multiple-marker screening is preferred over the other options for several reasons. Biophysical profile (option A) is a test used to assess fetal well-being and not specifically designed to predict chromosomal abnormalities in the fetus. The lecithin-to-sphingomyelin ratio (option C) is primarily used to assess fetal lung maturity and not for chromosomal abnormalities. Blood type and crossmatch of maternal and fetal serum (option D) are important for assessing blood compatibility but do not directly predict chromosomal abnormalities.
Educationally, understanding the rationale behind choosing multiple-marker screening can help students grasp the importance of specific tests in prenatal care. It highlights the significance of using a combination of markers to assess the risk of chromosomal abnormalities, emphasizing the need for a comprehensive approach in maternal monitoring. This knowledge is crucial for healthcare professionals involved in prenatal care to make informed decisions and provide appropriate support and counseling to expectant parents.